M. Ruhwald (Copenhagen, Denmark), J-P. Zellweger (Fribourg, Switzerland)
Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis
H. Kamiya, S. Ikushima, K. Kondo, K. Satake, M. Inomata, A. Moriya, T. Ando (Tokyo, Japan)
|  |
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection
L. Slogotskaya, V. Litvinov, Y. Kochetkov, E. Ovsyankina, D. Kudlay, P. Seltsovsky, N. Nikolenko, D. Ivanova (Moscow, Russian Federation)
|  |
Prevalence of long-lasting IGRA positivity in Portuguese healthcare workers
J. Torres Costa, C. Kesavachandran, A. Nienhaus (Oporto, Portugal; Hamburg, Germany)
| |
Impact of Quantiferon TB Gold intensity response in active over latent tuberculosis
F. Khan, O. Cotter, J. Clair, D. Curran, T. O‘Connor (Cork, Ireland)
| |
Tuberculin skin test and IGRA test in the diagnosis and follow-up of bacteriologically confirmed pulmonary tuberculosis in HIV negative adults
J. Homolka, I. Hricikova, E. Kopecka, M. Vasakova (Prague, Czech Republic)
| |
The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals, and controls with the TB antigens ESAT-6, CFP-10, and TB7.7
S.B. Kim, S.Y. Kim, M.S. Park, Y.S. Kim, S.K. Kim, J. Chang, H.J. Lee, S.N. Cho, Y.A. Kang (Seoul, Republic Of Korea)
| |
Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
A. Socaci, G. Nini, V. Tudorache, T. Moisil, E. Borgazi (Timisoara, Reunion; Arad, Timisoara, Constanta, Romania)
| |
Cut-off point for tuberculin skin test (TST) and QuantiFERON (QTF) in the diagnosis of tuberculosis infection (TI) in a study of contacts of tuberculosis (TB)
J.M. Garcia-Garcia, J.J. Palacios, B. Gonzalez-Gonzalez, A. Fernandez-Quiroga, H. Villar, M. Villanueva, G. Castaño, K. El Boutaibi Faiz, F. Alvarez-Navascues, A. Sanchez-Antuña, J.A. Gullon, J. Allende, M. Martinez-Muñiz, J.M. Fernandez-Carreira (Aviles, Oviedo, Spain)
| |
Evaluation of cut-off values of QuantiFERON-TB Gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis
E. Seyhan, K. Köksalan, G. Günlüoglu, S. Sökücü, N. Veske, A. Akbas, S. Altin (Istanbul, Turkey)
| |
Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting
T.S. Hermansen, V.O. Thomsen, P. Ravn (Copenhagen, Hvidovre, Denmark)
| |
Treatment in inflammatory bowel disease affects IGRA performance
M. Arias, S. Riestra, R. DeFrancisco, A. Pando, J.J. Palacios, P. Escalante, J. Belda, L. Molinos, M. García-Clemente, B. Palomo, L. Rodrigo, A. Prieto, A. Losada, P. Casan (Oviedo, Rochester, Valencia, Spain)
| |
Application of intracellular cytokine flow cytometry in the diagnosis of active tuberculosis
J. Lee, E.J. Kim, S.S. Yoo, S.Y. Lee, S.I. Cha, J.Y. Park, C.H. Kim (Daegu, Gumi, Republic Of Korea)
| |
Immune responses in the lungs of patients with tuberculous pleural effusion without parenchymal tuberculosis
W.I. Choi (Daegu, Republic Of Korea)
| |
Comparison of interferon gamma assay and tuberculin skin test in household TB contacts
S. Kasikovic Lecic, S. Pavlovic, V. Kuruc, M. Ilic, D. Kukavica (Sremska Kamenica, Republic Of Serbia)
| |
Experience of using Diaskintest by tuberculosis patients
L. Pankratova, N. Kazimirova, K. Klochkova, M. Ogareva (Saratov, Russian Federation)
| |